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REPORT  OF  'mE  SCIElfi'IFIC  OOMMITTEE  FOR  FOOD 
ON 
GUIDELINES  FOR  THE  SAFETY  ASSESSMENl' OF FOOD 
ADDITIVES 
(Opinion expressed 22 February 1980) 
5 .  . 
INTRODUCTION 
Definition of food additive 
Several deflni  tions  of  a.  food additive exist in national  a.nd  international legislation which 
differ  according to the purpose for which they are intended.  An  example  of a  simplified 
definition is the one  proposed by the Joint  PAO/WH.O  Expert  Committee. on Nutrition in 1955 
which states tha·t  "intentional tood ad.ditives ce :nonr-mrtri"ive  substances which  are 
added intentionally to food,  generally in 1111all  qua.n:titiee, to improve ita appearance, 
flavour,  texture  or storage properties".  A more  recent and wider definition covering food 
additives, whether or not  endowed with nutritive value, has been adopted by the  Codex 
Ali.mentarius  Commission and is quoted in the Fourth edition at the Procedural Manual iehed 
in 1.975.  For the purposes of these guidelines any substance is regarded as a  food additive 
which is added to food at ~  stage during manufacture with the purpose of  changing ita 
characteristics. 
Gener~lk~rinoiples governigg !he use of food additives 
Gener&l  principles for the use  of food additives were  elaborated at the first meeting of the 
Joint  FAO/WHO  Expert  Canmittee  on Food.  Additives  (JECFA)  held in Rome  in December 1956. 
These  principles are listed in the First Report  of the Joint FAO/WHO  Expert  Committee  on 
Food  Additives  published in 1957.  Similar general  principles  are applied by the Commission 
and by the EEC  Member  States in developing legislation on food additives. 
Apart  fran these  considerations other factors may influence any decision regarding the 
acceptability of a  food additive.  The  ex:irienoe  at the comparatively infrequent  phenanenon 
or  human  intolerance to substances foreign to the body oannot  be ignored,  whether this 
intolerance takes the clinical form  of hypersensitivity or allergy.  For certain classes 
of  a.ddi tives, e.g. flavourings,  organoleptic considerations mt\)'  be a  primary consideration. 
Bef'ore  an a.ddi tive is accepted for use in food,  it should have been subjected to an adequate 
toxicological  evaluation.  Implicit in this evaluation is the asswaption that the proposed 
level  of use does  not  exceed the lowest  level whioh is necessary to euure that the desired 
results in food manufaoturing practice are achieved.  Additionally, there  should be evidence 
of "need" i.e. that the proposed use  of'  the additive would have technological advantages 
and  confer benefit  on the consumer,  in other words it is neoessary to establish the case for 
what  ia commonly  ref'erred to as need. 
Food additives should be permitted by the appropriate authorities.  Legal  control should 
be  accomplished through the enforcement  at lists at permitted additives which  effectively 
prevent  the a.ddit:J.on of  &1\Y  new  additives to food,  until an adequate basis for  judgement  of 
their freedom  from health hazards has been establiShed.  Where  necessary, quantitative 
restrictions can also be incorporated in the relevant legislation. 
The  use  of an additive must  not mislead the  oonaumer as to the quality of the product  or 
encourage faulty processing and handling techniques. 
Conaidera.tio~!..Le!atiM tc__:'need" 
A "need" for a  food additive may be  olaiaed if the uae  of the additive gives  demonstrable 
technological,  eoonanio  or other advantages  at benefit to the consumer  • 
a)  :£e,2h~o,!.ofil  ~a! ~e!_d  _ 
In some  food manufacturing processes the use  ot ad.di  tiv·es is indispensable and  a 
technological  need therefore exists a  :erio:r:!o  For  exmnple,  margarine  cannot  be manufactured 
without  emulsifiers  and  jaJDS  oannot  be made  without  additives controlling the  pH. 
b)  Economic  need  - ......... - .... -
Additives  such as preserva.tives and antioxidants  enhance the keeping quality of foodstuffs 
thereby extending the shelf life, reducing wastage,  and  providing a  wide  range  of foods 
for large urban populations at all times of the year a.t  tolerable prices.  The  use  at 
additives to enhance  shelf' life m~  be  claimed to be the fulfilment  of an economic  need. 
7 other considerations 
The  aesthetic appeal  of food is of  importance and food,  which  is una·ttraotive to the consumer 
will not  be  eaten and therefore wasted.  Customs  and tradi  tiona determine the expectations 
of the  consumex·  and :tood which  does  not have the appearance  and texture within the nonaal 
range  of variation to which the consumer is a.ooustomed,  will be rejected.  Organoleptic 
factors inf'luenoe the a.ooepta.bility ot food by the  consumer  aDd  are de·termining factors 
:f.nfluenoing the food  trade.  Although  no absolute neoessi  ty oan be established in every 
oiroumetanoe, it oan be  claimed that there ia a  peyohologioal  need for colours  and flavours 
in some  foods. 
Once  the technological  need and  value to the  consumer  of a  food  additi,..re has been established, 
a  decision ie required regardj.ng the implications for the health of the  consumer  due to the 
presenoe  of  tha.t  ad.ditiva in food.  Even it additives have  been consumed f'or many  yeara  by 
man  without  e-~tiden.ce  of acute adverse etteot, it is misleading to argue, that their use 
might wall involve lees risk to the  consumer than new  additives which,  although tested 
on animal a,  have  not  previously been ooDSumed  by man. 
Ae  it ia extremely d.iffioul  t  to establish whether  continued consumption of an additive  over 
many  years  causes  chronic effects in man,  its prior consumption by man  cannot  be regarded 
necessarily  a.s  addi  ti.ona~ evidence for sa:tety. 
In par-tioular1  it is necessary to determi.ne 1Jy  taxioologice.l  examination whether the 
m1.bstanoe,  whe11  used in the manner and in the quantities proposed,  might be injurious to 
the health  of those population groups whoae  pattern of food  ,:consumption or physiological 
status,  e.g  •.  age,  pregnancy,  makes them the most  vulnerable  ones.  A number  ot procedures 
ft.Xiet  for oondJlcting such toxicological examinations.  No  fixed programme  should be laid down 
to be followed 1"igidly in every case, but  a  framework is proposed tor planning a  sequence  of 
steps -which  enables the safety-in-use at a  food additive to be evaluated.  The  toxicological 
exa.minat:i.on  provides the d.a:ta  tor such  an asaesemeu:rt.  In general  one  must  rely on experimental 
data derived from  investigations in laboratory animals.  If the biological action of  a 
substance has been a.soerla.ined qualitatively and quantita:t:tvely in d.itferent laboratory 
animals,  the likely effects on man  oan then be  estimated by careful  extrapolation.  Where 
available,  one  may  also use human  data derived f'rom  medical use,  occupational  epide11iology 
or specific studies  auoh  as studies  on critically exposed groups. 
The  procedures to be  employed for the testing of intentional food  a.ddit:i.ves  and for 
tnterpre·ting th.e  resulting data have been disou.ssed in aany national  and international 
~lblications, since first euunciated b.y  the Joint FAO/WHO  Expert  Committee  on Food Additives 
in 1957.,  As  the  science  of toxicology has adva.noed,  so the proposed procedures have been 
modified  ~Uld updated where  neoess&I~. 
In any evaluation of food additives two  stages are discernible.  Tha  first is concerned with 
the  eetabli.ahment  of  adequate  and reliable qu.alita:tive and quantitative data describing the 
biological s.ctivi·tiee  of the  eubstan.ce under examina.ti.on.  '!he  second stage is concerned 
with the interpreta:tion of these data, their correlation with  other tU!U!Ientia.l  information 
on the physical  and  chemical  properties,  and with estimates  at the exposure  of ·the  population. 
Since the  consumer  m~  ingest the submtanoe  daily over the whole  ot hie life time,  the 
maximum  intake from all souroea  needs to be  estimated,  which will cause  no  obvious detrimental 
effeat  on the hea.l·th  of the individual. 
It i.e  only possible to formulate  general guidelines defining the scope of the examinations 
required, their sequence  and interpretation in terms  of  a.ooepta.ble  i.ntake ·by  ma.n. 
Consultation with  competent  ex:perts  concerning the proposed examinations,  the methodology 
to  be  a..pJllied,  the method  of reporting aDd the presentation at the  evaluation is advisable. 
In general 'the proposals in these guidelines are intended to apply to the evaluation of new, 
or the reevaluat:ion of already established intentional food additives, directly incorporated 
into food  and fulfilling a  defined teohnologioaJ.  or other purpose {as already outlined on 
page 7).  'P.hey  may  not  necessarily apply in :t"ull  to non-intentional add.itives  1  accidentally 
incorporated into f·ood  a.a  a  result  of prooeseing9  packaging or  oa.r~over from  ra.w  commodities. 
These latter are  considered under "Special  Cons:i.dera.tions"  (page 2l)o 
8 The  d.iverei  ty of  chf'Jnica.l  s-tructure and technological function  of  addi  tiveo  precludes the 
esta:blishmBnt  of  a.  single uniform pattern of test procedures  covering all substances.  Each 
substance presents ita own  particular problems  and  the  planning and  oon.duct  of the 
tox:icolog:i.cal  examina·tion remains the responsibility of:  the scientist testing the substance. 
The  examination must take aocoWtt  ot all available knowledge  regarding the  substance and 
of  any toxicologically rela·ted  compoundao 
!!.1-...  e  impozi;.al'\o  ..  e  t)f  R8,yaioo-ohemioal  information 
A knowledge  at the  chemical structure,  of the physioo-ahemioal  characteristics and  of the 
spatial  conformation of the molecule  of a  substance is important for the proper design of 
the appropriate toxioologioa.l test procedures.  Thus knowledge  of the volatility, solubility 
or pH  of  a  substance will  detert.rdne the nature ot its ad.rni.nistration to the experimental 
animals.  Information about the  chemical  stru.oture and,  where relevant,  of the spatial 
oonforma;t,ion will  permit  some  ooncl".sions regarding its likely biological activit,. 1An 
example  of  a  suitable  scheme  is given in Annex  7  ot the Oounoil  Directive 79/831/EEC  even 
though that Directive is not  confined to aubata.noes  used as food additives. 
ll'!.!  ....  t.!P.ortanoe  of  speoificaj;i.ol'l;s in eatet:  eval.~tion 
'l'he material eventually subject to to.xioologioal testing should correspond to the f'ood 
a.ddi tive ·to  be  used in practice by the food industry. 
'Jloxtoologic.al ·tests,  carried out  on samples:f'or whioh there are  inadequate speoi:f'ications, 
may  later be found.  to be valueless tor a  proper evaluation of the materials to be used in 
practice 'by the food industry, while teats ll&de  on an unidentifiable ma:teria.l  are worthless. 
Thua  a  food  add.i tive must  conform to appropriate specifications.  Tttis will  ensure that it 
oan be  properly .identified and that the presence  or all, but particularly the harmtul' 
impuri.ties is reduced  ·~o  acceptable levels.  Consideration of the chemical  structure,  and 
the  rou-te "by  which it has been synthesised, will enable  a  search to be made  for specific 
potential  :i.mpuri ties whos&  presence aight  otherwise escape deteation.  If the method 
of manufacture  of  an additive is changed,  any alteration in the nature and  amount  crt 
impurities must  be determined,  and  a.  revised speoi:tioation produced if appropri.ate.  In 
the elaboration of an additive speoifioation consideration should be given to degradation 
products that rna.y  arise during formulation or storage,  and to the possibility of interaction 
at the additive with other substances present in tood.. 
In principle,  an adequate method  of analysis is  neceesa1~ for iderrtifying and  determining the 
quantity of additive present in or on the food.  If an analytical method is not  available, 
it is neoessax:y  to consider,  as an alternative method  of control, :factory inspection 
irNolving examination of wei.ght  records. 
Labor~t.P.rz.  ...  cll..et  a.nd  ...  ~mal  husband;t::Y 
Adequate  info1~tion on these aspecta requires a  full description of the animal diet used 
in the biological  studies.,  This  should include the oOII\posi tion, the results of analysis 
for macro- and  micro-nutrients,  and  of analysis for the presence  or absence of toxicologically 
important  contaminants,  e .. g. mycotoxins,  organochlorine  compawl.ds,  n.itrosamines,  pesticide 
residues,  toxic heavy metals,  etc.  In addition a  description i.s  needed  of the  conditions 
of husbandry,  distribution and  environmental  oircumsta.ncea to enable an eventual  evaluation 
of the  experimental results. 
Int"ormati.cm is needed  on the absorption,  distribution in the  body,  bio-transformation and 
ex.oretion of the  eu.batance,  and its metaboli.tes,  in la'bora:tors  animals,  and,  if possible, 
in man.  Fttrthennore,  the potential for causing toxic reactions  needs to be fully explored. 
1counoil  Directive  of 18  September 1979  amending for the sixth time  I>irec·tive  67 /548/EEC  on 
the apprax.ima.tio.n of laws,  regulations  and administrative provisions rela.ting to the 
ola~.:>sifica.tion,  packaging and labelling of dangerous  substances,  OJ L  25 9,  15el0.1979t  P•  10 
9 Testing normally starts with  a  determination of acute toxicity.  In relatively rare instances 
the substances may  exhibi·t  unacceptable toxicity at this stage, leading to the abandoment 
of further studies.  The information from these tests normally provides uae:f'ul  baakground 
and guidance for further tests. 
Toxicological  &Bseasmerrt  should next  prooaed to an examination at genetic toxicity a.s  an 
early screening measure to give wa.r'Jling  at poaaible oaroinogenio  or mutagenic potential. 
Then the metabolism,  including pha.rmaoold.netioa,  at the subria.noe  should be  examined.  If 
the metabolic and  pha.rma.oiki.netio  stud.i.es  reveal the forma:t.ion at substances normally 
ooourring in the bo<\y,  a  safety asses1!1Dl.e!R  mq be posaible at this stage.  If'  &l\Y'  of the 
m&jor metabolites are :found to be  subriaDCes with known toxic properiies or with  unknown 
biological aotivi  ties, teriittg must  corrtiDUe tor subohronic eft  eats and ahronio effects, 
where indicated.  Studies  on placerrtal transfer, reproductive etfeots a.nd  teratogenicity are 
also needed.  Axzy  etteota fou.nd at the stage ot nbohronio testing require evaluation to 
deoide whether the,y will present  a  taxioologioal riSk under actual exposure  conditions. 
'l'he  c-.hronio  toxicity and  poaeible carcinogenicity or  a  substance alwB\Y•  require further 
detailed etud;y  and evaluation, whenever the eubata.noe has  a  chemical structure suggeriing 
the posei  bili  ty of oaroinogenioi  ty,  or shows  effects in subohronio toxioi  ty teats  su.ggesti~ 
more  serious oonsequenoes  on longer expotnJre1  or shows  possible adverse effects in the genetic 
toxicity studies,  or if' the metabolic iDV"eriiga.tiona  suggest the production of rea.otive 
intermediate metabolites,  or it the additive ie likely to be  consumed at  a  substantial level. 
'!'he  outoane  of the chronic taxioity tests permits  a  final decision to be taken regarding the 
aoceptabil:f.ty  c.1f  rejection at the substance.  Por more  deta.i.led protocols or the studies 
oonsidered below see Annex. 
Axcy·  system being developed should attempt to ox•ganize the e:x:istil18 knowledge  on safety 
assessment in suoh  a  WfJ3  as to permit  ju.dgemema  at  oonseou:tive stages in the toxicological 
examination  of"  a.  substance.  As  specified tests are completed, the toxicologist  should decide 
whether a  decision on satety oa.n  already be taken in the light  at the results obtained so 
tar.  Alternatively a  decision is needed  on whether the subria.noe  ought to be  re~ected, or 
whether to co:rrtinue testing.  However,  in principle, it is desirable that aey food additive 
should be fully examined for all toxioologioal~;potetttialities betore its safety-in-use can 
be accepted  (see also "Special Considerations",  page 21). 
a)  !...~te toxio.;.tz studies 
The results of acute tootioity tests provide a  ba.aia for the ola.ssitioation af a.  substance 
in tet"mS  of its relative toxicity compared to the known  acu.te toxicity at stnctmzally 
similar aJ"Jd/or  biologically related substances.  Acute taxioity tests also furnish 
prelimin..q,ry inf'onna.tion on which to base the dosage  range f'or feeding experiments  at longer 
duration, by determining the dose levels whioh have  or have not  an etteot  on the experiraenta.l 
animal. 
Furthermore,  acute studies prwide information about the target  organs  as determined by 
gross poet......mortem  examina:tions.  They may prwide ueef'ul  information 011  the probable mode 
of a.cti on and  evidence  C1f  the hazard to man to be  expected in oase  of excessive  expoB\U'e 
thrOl~ accident, misuse  or occupational handling. 
'l'h.e  manner  a!  a.drnin  .. i.stration of the substance should reflect the potenti.a.l  route  of human 
exposure.  In case  af food additives the oral  r011te ia essential.  The teats should be 
conducted  over an observation period. of at least  2  weeks  and in more than one  small laboratory 
species. 
Muta.tion refers to those  changes in the genetio materi.a]  of  sa:nA.·tio  or germ  cells brought 
about  spontaneously or by chemicals  or radiations, whereby their euooessors differ in a 
permanent  and heritable way from their predecessors. 
Sane types  CJf  mutation ~'V :not  be m&l'lifested for m.a.n;r  generations.  The  de·tection of chanicals 
·that m~  be  pote11tial  human mutagens has reoently been a  rapidly expanding tield.  This is 
beoa.use,  apart fran the serious implications tor future generations if addi.tiona.l genetic 
diseases are  added to the far from  negligible current bu:rd4)n,  there is evidence that 
somatic cell muta;tions,  as  opposed to gem.  cell mutations,  m.tQ"  be associated with the 
development  ot certain types  a£  oa.noer. 
10 Damage  to the gen£,tio apparatus may  be at the level  of individual genes  (gene mutations)  or 
the interference may  be  a  grosser type in which the structure of the  chromosomes  (structural 
chromosomal  aberrations)  or their ntUBber  (numerical  chromosomal  aberrations)  is altered. 
If the structural alteration is small and results in the deletion of  one  or a  few  genes,  the 
net  effect may  be difficult to demonstrate visually and to distinguish from  a  gene mutation. 
A wide variety of  procedures has been 4evised to test the ability of a  chemical to induce 
these various kinds of mutations in organisms  rangi.ng from bacteria (prokaryotes),  with the 
simplest arrangement  of the deoxyribonucleic aoid (DNA)  molecule,  to organisms,  in which 
the  DNA  is arranged in a  most  complex aseooiation with  proteins and  enzyme  systems  ( ahraaatin) 
to fom the  ohromosomal  system found in phyla rangi!J8 from  fungi to insects and finally 
mammals  (eukaryotea). 
It is known that ma.ey  chemicals possess mutagenic properties which  present  a.  potential 
hazard to future  generations  and thus there is a  neoesaity to identify and limit the  spread 
of  chemicals with  such  properties into the human  environment.  It is therefore recommended 
that  any  new  food additive should be investigated !or mutagenic potential by testing 
procedures which  cover berth  gene  a.nd  chraBosane damage,  both in vitro and in vi.vo.  In 
thi.e way  some  evidence m~  be provided upon which  a  preliminary &seessment  of a  possible 
mutagenic hazard can be based.  If for aey reaaon suspicion should arise about  any food 
additive already in use, it should also be  aubjeoted to these teat procedures.  It is clearly 
impractical for  aey tes·ting routine to cover the entire spectrum  of genetic to.xici  ty teats 
currently available.  However,  there is considerable and  growing scientific evidence that 
the majority of potentially mutagenic  chemicals  can be detected by a  canbination of teat 
procedures selected in such  a  way,  that the hereditary machinery is tested systematically 
at increasing levels of  complexity.  A sequential approach also permits  some flexibility in 
the choice  of equivalent  genetic targets. 
A suggested battery of screening teats for carcinogenicity and mutagenicity investigates 
the following genetic endpointss 
i) 
ii) 
The  detection of  gene mutations in bacteria both with  and without the use  of mammalian 
metabolic activation systems.  This is incontestably the most  widely validated  system 
in the field  of genetic toxicology and it ia also believed to be the most  sensitive. 
Once the aoti.vity of  a  chemical  on the reversion DNA  system in microorganisms has been 
clearly established, all further testing ahou.ld be  carried out in systems which 
utilize higher eukar,yotes,  preferably mammals. 
The  determination of the ability to produce damage to the  chromosomes  of mammalian 
oells grown in vitro (metaphase analysis).  This  procedure has particular relevance 
in that human lymphocytes  could be uaed. 
iii) The  testing of the ability to penetrate to,  and in:teraot with,  genes in the  complex 
arrangements  of  DNA  in eukaryotic oells in vi  tr~ (fungi, yeasts  or mammalian  oell.s)  or 
,in viv:o  (Drosophila melanogaster or mice). 
The  bacterial genome  is not  only relatively simple  compared to that  of the eukaryotic 
cell but it is, particularly in specially constructed test organisms,  readily accessible 
to  chemicals.  Hence  suitable mammalian oell techniques based on detection of mutations 
at specitio gene loci are employed.  The  mammalian cell grown in oul  ture does  not  possess 
the metabolic  capaoi  ty of the intact animal  and thus it is necessary to conduct all 
in vitro tests with and without the provision of  supplementary metabolic activation 
systems. 
iv)  The  determination of mutagenic activity in in vivo tests in a  mammal  because in vitro 
systems neoeesa.rlly fall far short  at the metabolic possibilites in the intact muaal. 
A variety of tests  is  available at present  e.ge~  metaphase analysis of bone marrow in 
the rodent,  the micronucleus test in the rodent,  a  dcainant lethal teat  i11  the rodent, 
which latter may  also be  carried out in conjunction with  a  multigeneration reproduction 
test. 
v)  If circumstances specifically demand it, it m~  be desirable,  as an adjunct to this 
battery of screening tests for carcinogenicity and mutagenicity, to a.sea.y  also for 
primary non-specific damage to DlfA  or stimulation of unscheduled DNA  synthesis, to 
asstcy"  for cell transformation using appropriate in vitro oul  tured mamaa.lian or human 
cell lines, to test for induction of heritable tranalooa.tions a.nd  to test for somatic 
point mutations in rodents. 
,, Positive evidence  of binding to DNA,  of the production of active metabolites in body fluids, 
and  of cell transformation lends  considerable support to regarding other evidence  ot 
mutagenicity as indicating the existence of  a  definite carcinogenic potential requiring 
verification by chronic testing in animals. 
c)  Metabolic....._includi!lfi pharmaookinetic studies 
Metabolic  and  pharmacokinetic~ data are vital oharaoteristics of  a  compound  and are needed 
tor planning approaches to safety evaluation, tor designing protocols,  selecting the proper 
teat species,  defining the dose  regimen,  and for appropriate  conduct  of the studies.  Until 
recently the principal  justification for developing this information was the value of 
interspeoiee and interstrain comparison in order to select for toxicity tests those  species 
and strains most  closely resembling man  in regard to the metabolic pathways  of the  oanpound. 
However  in the case  of food additives, in contradistinction to drugs, it is much  leas often 
possible to etudy human metabolism.  Here studies in non-rodents  and  non-human primates may 
be  useful  arui  may  provide  an indication of the relative importance  of possible metabolic 
pathw~s for a  test  compound;  such studies are never a  complete  substitute for investigations 
in man  but  represent  a  practical  approach,  if human  studies are  not  possible.  Qualitative 
simila.ri  ties regarding the na.tu.re  of metaboli  tea formed may  not  reflect similar rates of 
formation  and phannacokine·tios in different species.  Moreover,  valid conclusions ae to 
metabolism  carmot  be  drawn from  comparisons  of results derived from testa carried out under 
different  dosage  regimens. 
To  provide a  general  overview  of the :fate  of  a.n  ingested substa.nce in the 'body,  a  number 
of  relatiV"ely  simple studies may be  pertormed.  Because metabolic differences are known 
to exist  even among  different strains  of the same  species an additional  stu~ to eliminate 
this possibility m~  be useful at this early stage of investigation.  In vitro procedures  such 
as investigation of acid,  alkali  or enzyme hydrolysis,  and possibly the use  ot pertused 
organs may  yield useful data.  Possible interactions ot the test  compound  with food 
components  and likely changes  at the teri compound,  while it is on or in the food,  require 
consideration. 
The  teet  compound.  may undergo  degradation in the gastro-intestinal tract,  or may  interact 
with  substances present in the intestinal content a.  Degradation may  occur by physico-
chemical means  or by enzymes  or by biodegradation through the action ot intestinal bacteria. 
Under the latter circumstances individual variations may be  noted within groups  of animals 
as well  as within different species.  In vitro tests with  gut  contents or with  cultures of 
isolated aerobic gut bacteria may  be uaetul indicators of potential degradation,  when the 
test  compound  ia administered orally in vivo. 
If there i.s  stringent  evidence that the  compound is not  absorbed af'ter ingestion, further 
metabolic: studies may  not  be  needed,  but  non-absorption in one  set of circumstances may 
change with alteration in the gut flora.  The  identification of  a  highly toxic metabolic 
product  may  render the parent  oanpound unacceptable tor use  i.n t'ood.  Data indicating the 
physiological handling of the metaboli  tee may  be  encouraging evi.denoe  of safety. 
To  check the variety,  nature and  range  at metabolites formed,  preparations fran  animal  or 
human  organs m~  be useful.  Tests using isolated miorosomes,  liver cells,  perfused 
organs,  whole  bo~y or other forms  ot radio-autography,  and the detection of the capacity 
of  a  compound  to form  cheouboally reactive me·tabolites provide insight into the toxic 
potentialities of the teet  compound,  give cluea to the anderetanding of species differences 
in toxicity,  and.  contribute to the extrapolation of test resul  te in animals to man. 
For any given chemical there ma..y  'be  numerous  and d:i.verRe  pathways  of biotransformation. 
Usually the effects  of age,  aex,  diet,  enzyme  inducers  and dose upon rates of formation, 
d.i stri  buti  on  and excretion at metaboli  tee  cannot  be  predicted  ...  Hence metabolic studies are 
conducted with  radioisotope-labelled compounds  to identify the main metabolites, their 
conjugated  deri-vatives,  the quantitative and temporal  rela·tionships  of uptake,  distribution, 
retention and  elimination of rm.dioa.otivi  ty,  and  ohangea in the metabolic pattern with 
va.ri ous  doses of the test  compound.  Both untreated and  "a.d.a.p·tedu  animals may  have to be 
investigated. 
i!The  tenn 
11pha.nnacokinetics
11  ie used in these guidelines but  a1 terna.tive terms  a.re 
"toxicokinetioe"  or uchemobiokinetios". 
12 Comparative metabolism  should be studied in those  species and strains likely to be  used for 
subchroni. c  taxici  ty tests a.nd  dose  effects should be investigated also in those species 
eventually to be utilized for loll€-term feeding expetriments.  It may  be desirable for  sane 
metabolic work to be  carried out  in non-rodents e.g. dogs  or  no~uman primates. 
Ideally,  phamacokinetic information should be developed as  soon as subchronic repeated 
ad.min:i.stra.tion tests are  contemplated,  but this depends  on the availability of appropriate 
assay  methods  or of the radiolabelled compound.  The  objective is the gathering of data 
on the apparent volume  of distribution and rates of absorption,  d.istr:l.bution and  elimination. 
Cornrentionally a  single bolus dose is administered by gastric intubation and  a  simple 
balance  study is carried out  in blood, urine, faeces, bile and possibly cerebrospinal 
fluid. at  predetermined intervals over 96-120 hours.  This  provides  a  general view  of the 
intake-output relationship of the  compound. 
M.ora  e.rtensive investigations are  needed to gauge the effects of very high.  doses,  to chara.ct-
eJ•i.ze  ·the major metabolites formed  and their rela.tiv0 proportions,  as well  as to provide 
information on tissue distribution and tissue levels, target  organa  and  the nature  of the 
toxic me chard.  rJllls. 
d)  Subohronic studies  .  -~ 
'l'he  primary objective  of  a  subohronic  stud;y  a.s  part  of the taxicolog;  ..  .:::al  appraisal  of  a  food 
a.dd.i tive ie the  oha.racterieati.on of its physiological  impact  following repeated administra.tior; 
0\rer  a  significant frac·tion of the life 19pan  of the ·test  Bpl!?:oies.  Subchrotrl.c  studies also 
permit  a  judgement  on the need for additional  or more  exterrled studiee to delineate more 
clearly the toxicological profile  of the substance under teat.  They are invaluable for 
determining the appropriate dosage levels for oondu.(,-ting  chronic toxicity studies,  because 
'they  provide  i.nfo:rma;tion  on the major toxic ef'feots  of the test  canpound.,  on dose-response 
relationships  and  on the reversibility of  a..ey  phenomenon observed.  Apart  from giving an. 
indication of the minimum  dose  causing any toxi.c ef'feot,  such  studies point to the existence 
of  species differences in the nature of the response and to the effects  of  environmental 
variables on the characteristics of the observed toxicity. 
A major  objective  of subchronio studies ie the esta.blilllhmer!t  of the spectrum  of 
toxicological  effects of  a  compound, their nature and  severity, in an animal  species in 
which  the metabolic  pathWS\)YS  of the same  or a.na.logous  substances are as similar as possible 
to those  i.n man. 
In many  inatanoes it has been possi  blrJJ  to make  a  judgement with  respeot to the sui  ta.bili  ty 
of  a  substance as a  component  of the human  environment  on the basis of the results  of 
su·bchronio studies.  The  extent to which  subohronic tests can be relied upon to evaluate 
the  sa:fety  of  a.  substance depends  on a  number  of factors  suoh  as  chemical  structure, the 
nature and ex-tent  of human exposure,  and the  ch.ara.oter  of ·the biological responses of 
animals to exaggerated dosage with the  compound. 
Conventional  subchronic taxi city studies are usually limi·ted to dietary exposure of two 
laboratory species for  a  period varying from  90  days to 1  year,  generally representing lo% 
of the life span of the  speoies seleated.  In the  common  laboratory rod.ents  e.g. the rat, 
mouse  and hamster,  ·this  per:i.od  extends oonventionally wer 90  days.  In the longer lived 
species,  such  a.s  the dog,  pig &nd  subhuman primates, it may  be  extending over 1/2-2 years. 
One  rodent  and  one  non-roderrt  species should be  employede  Tra.di  tionally ·the  rat  and the 
dog  a.re  used,  but  a  second rodent  epeoies,  the mouse,  is fr$Ciuently  resorted to beo&use 
of ita a.vailabili  ty and relatively short life span.  In order to berud'it  from the existing 
data base  and  background information it is preferable to use  commonly  employed strains of 
rodents,  unless knowledge  of the  compara:tive metabolism  arui toxic effects  of  t.he  substance 
in man  and  other species diata:tes  o·thenrt.ee.  Both  sexee  should be  studied in order to 
detec·t  differences due to sex hormone  effects. 
On  the basis of acute toxici:ty data and  on estimated or predicted :hrtak:e  levels uncler 
oondi  tiona  of use,  at least three dose levels excluding controls are selected in the hope 
of bracketing the  "no  observed adverse effect" level for the species under the specific 
condi  tiona.  At  least  one  dose level should reveal  an  o'bssrv·a.ble  effect,.  It may  be  expedien1 
to initiate the study with larger munbers  CJf  test levels and to di.soontinue  those which 
prove too toxic after the first few  weeks&  Th1ring this period,  sigllificant  deviati.ons  from 
control data in any  observed parameter are considered "effects"  observed.  The  degree  of 
significance depends,  of course,  on the size at groups  employed,  the  number  of  animals 
13 exhi.biti:ng adverse  oigns,  and their aeveri·ty.  The  number  and  extent  of the examinations 
made  in such  studies vary  somewhat  with the known  properties of the  compound,  a.nd  the 
purpose  of the tes·t, but it is useful to establish a  routine of careful  clinical 
assessm·ellt. 
One  problem  i.n the evalua.ti on of observations during the terminal stages of  a.  subchronic 
study is the degree  of  importance to be attached to reversible clinical and biochemical 
findings.  Reversible  changes may  represent  a  biological response to stress.  The  stress in 
such  cases 1Jeing the a.d.a.pta.tion to  a.n  unusual  load on some  metabolic pathway through whioh 
the an.imal  attempts to mi  t:J.gate the  effects ot the  substance by accelerating an existing 
enzyme  reaction,  initia.ti.ng a  new  one  (enzyme induction),  or overtaxing an excretory process. 
An  example  of  a  commonly  seen reversible effect is the mild liver enlargement frequently 
obs.:~ervefl after feedil'lg'  certain compounds without  any detectable alteration in the histological 
a,rchi teoture of "the  orga.n.  To  investigate .reversibility with  a  view to evaluating this 
phenomenon,  some  proportion of the survivors  of a  subohronio study should be  continued  on the 
basal  control diet for up to 3 months after cessation of  exposure  and then examined for 
raverBaftl  crt  the adverse  eft'ects  seen in those sacrificed earlier.  Kinetic stud.ies M83f 
assist in determining the appropriate exposure  and reversibility periods. 
e)  Reprod~ct.iol!_~  teratoge_~o:i.ty stu£11.t!s. 
The  purpose  of reproduction studies is to provide information about the possible increase,  in 
euccessive generations,  in sensitivity to a  ~tbstance, the effects  on the fertility of male 
and female  anima.ls,  the detection of any pre-, peri- and  post-natal effects  on the  embryo, 
the :f'oe·tus,  and the you:ng,  including any teratog·onic and mutagenic effects,  and the 
discovery of peri- and  poet-~tal effects on the mother. 
The test  should  comprise at least  two filial generations  and the active substance is 
administered throughout  the test at several dosage levels.  Thus  weanling animals are 
reared to maturi:ty  on the test diets, mated,  and the i"lla  or Flb progeny carried through  a 
complete maturation and reproductive oyole.  The  process is repeated for the F2a and F2b 
and.  where  a:pplicallle for ·the F3a and F3b generation.  In the course  of.  these studies all 
the  conventional behavioural  and clinical observations are made,  supplemented by data for 
reproductive efficiency and  performance.  In addition the usual indices a.re  determ:i.ned for 
concep·tion and ;r.estation,  the number and size at litters, the weights  of  pups  at birth, 
their via:bility,  Sl.ll'Vival  and growth through lactation.  The  study design should permit 
observations  on fertility of the males. 
The  ~ose levels to which  the animals are exposed  should be  similar to those used in the 
long-t0rm studies.  However,  one  of the dosages  should be  designed to exhibit the adverse 
effects to be  expected from the subohronio oral toxicity studies.  Laboratory rodents are 
to be  preferred though  other anima.l  species :mor:i:t  consideration. 
The  induetion of teratogenicity is one  o'f  the possible adverse effects  on human  reproduction 
dur:i.ng gestation.  A  teratogen may be defined as  a.n  agent  that  produces  permanent  structural 
or functional  damage  during embryogenesis,  the net  effect being a  congenital malformation or 
organ malfunc·tion which  iB  usually, but  not  always,  detectable at birth.  Thus  teratogenesis 
is  a.  post•  ... iJ:ametic  phenomenon which  theoretically could act  at any time after the first 
cleavages  of'  the  implanted zygote.  A mutagen,  by contrast  1  acta  on the gametes at  some 
ata.ge in their development  from the germ oell stage and  produces  a  heritable genetic alter-
ation in 'these  cell a.  Tera.togens are u.sually considered to act during the stage  of 
organogt.,neai.r~,  the classic example  of  a  chemical teratogen being thalidomide.  The  detection 
of  an  emrironmenta.l  teratogen affecting man  at present  can be ascertained only by 
retrospecttve surveillance which is a  difficult and unrewarding but  necessary procedure. 
Prospe<}tive  animal tests should therefore be designed to give  some  reasonable probability of 
tnferriDt~ that  a  substance poses  a  potential teratogenic hazard to man.  Unfortunately 
knowledge  of the many  fac·tors  tha-t  may underlie the induction of teratogenesis by a  chemical 
in a  hwnan  embryo is apa.:rae.  The  Choice  of an animal  model,  and the actual teet design,  must 
be  therefore la.rgely  ~..mpirioal  and to a  considerable degree  each  substance tested must  be 
considered  a.s  a  separate experimente  At  present there is no feasible alternative to studies 
ca.rri  ed.  out  in a  pregnan-t  mammal. 
All  new  food addi.tives,  and those in current use if suspicion arises,  should be tested for 
teratogenicity in at least two  species.  The  practical possibilities are the mouse,  rat,  or 
rabbi·t;  in eertain ciroumstanoes  other species have been used,  e.g. the hamster and the 
guinea pig.  It is essentiLl that there  should be  extensive baCkground knowledge  of the 
14 strains of  animals  chosen.  The  accumulated data on all the defects  observed in the past in 
untreated. animals  of the  ohosen strain fonn the historical control group.  This  information, 
together with details of the particular species and strains used in the studies must  be 
presented with the results.  It is desirable that  one  of the species  chosen is the  same  as 
that used in the  chronic toxicity studies.  The  design and  conduct  of teratological 
test:l.ng is a  matter that  only well-qualified and  experienced toxicologists  should undertake. 
They will be aware  of  controversial matters, the possibility of controlling the many 
experimental variables in the actual  ciromnsta.noes  of the trial, of the protocol that is 
most  sui  table for the individual chemicals under test,  and that  no  one teet system  can be 
specified, ·that will indicate with absolute certainty whether a  ohemica.l is potentially 
teratogenic for man.  The  available methods  are empirical and thus  only general  principles 
can be usefully indicated.  Teats should be  conducted w1 th scrupulous attention to the 
d.etails of the particular teat d.esign that is judged to be most  sui  table in the 
circumstances. 
As  an alternative to the  separate setting up of teratological studies involving exposure 
only during fixed periods  of  organogenesis, it has been suggested that a  portion of the 
pregnant  rate of  one  of the  generation~~ of  a  multigeneration study are used :for 
teratological investigations. 
The  data supplied by this modified teratological phase are quite adequate in terms  of the 
numbers  a.nd  types  of  observations.  They differ, however,  from  most  published procedures in 
that  exposure  of ·the  dam  is continuous  trom the manerrt  of ineeminati  on to the  end  of 
pregnancy.  In cases where the  number  ot implantations is reduced,  an increased incidence 
of  abnormaJ.i·tiea is observed,  the relationships between dose  a.nd.  severity or frequency  of 
effect appears  significant,  or it is desired to establish the embryonic stage at which the 
conceptus is most  aensi  tj.ve,  appropriate teratological testing in greater depth may  be 
required. 
It  shoul<i  bt~  remembered that,  although  a  dose-response relationship exists, it may  not  be 
easy to  rh~monatrate this clearly in teratological studies,  since the intervention of maternal 
metabolism  a.nd  the protection afforded by the placental barrier are important  complicating 
factors. 
f)  r~rq,!lic tq;xicity and caroinosenioity  studie~ 
The  objective of  chromo testing in animals,  by exposure for most  of its life span to the 
test  su'betance by an appropriate route and at appropriate dosage,  is the assessment  ot 
potential to.xi.oity a.s  a.  result  of  lo~em, low-level  exposure.  Such toxicity ll8J' not  be 
evident in r.nibohronic  studies in test animal B  a.nd  comprises  cancer,  oertai.n irreversible and 
progressive forms  of toxicity,  and toxicities depend.ent upon age-related sensitivities 
af  certain tissues.  This type  crt  experiment is wbjeot to man;r  potential variables which 
are diffioul't to con:trol  and which ma;y  intluenoe the final interpretation of an experiment. 
<.'hronic ·testing,  despite its relative insensitivity and procedural limitations, is however 
at preaeut the only appropriate method to evaluate the potential risk of progressive 
irre·v·ersible toxicity or  of carcinogenicity. 
The  mechanisms  of  carcinogenesis are not at present clearly understood.  Physical,  chemical, 
biochemical,  hormonal,  nutritional, genetic, viral a.nd  other factors may be  imrolved. 
Direct  oli.nioa.l  evidence  a.nd  epidemiological  riudies in man  oan make  a  considerable 
oontri  bution ·l;o  the determination of ohronic toxic hazards,  whilst human  evidence  of 
oaroinogenici.ty lvould militate against the a.oceptability at a  subata.no• as a  food additive. 
The  role  of  immunological  reactions in relation to carcinogenesis is not fully understood 
at preserrt  but  should be  considered in hazard evaluation where  justified by appropriate 
'  fi.ndings. 
For food additives it i$ recommended that  combined protocols be used tor studying chronic 
·toxicity a.n.d  oarcinogenioity in the same  e.xperimerr~.  Mos·t  at the procedures for carrying out 
such  chronic studies are relatively standardized but  several area&  are still considered 
oontrov·ersial.,  The  selection of test  speo:i.es  is limited by many  practical considerations, 
a.l  thou~;h the animal  model  should be 'bioloAica.lly appropriate for the toxicological  assess-
ment  of the  possible human riSk.  This implies that metabolism and pharmacokinetics  at the 
teat substance in the species  and  strains chosen should mimic those in man  as closely as 
poasiblee  For food additives 'both mioe  and rats are the traditional  ~peoies employed, 
l)eon.uae  nf  thtt  relAtively slH)rt  life upa.n9  riiza,  co•t  and  e.xteneive  exporianoe  and  n.vail-
nbil:lty  of  .illt'orma·ti.on  on their biologioa.l.  oharaoteristios.  :Both  speoies have to be used 
in most  circumstances unless specific considerations dicta:te otherwise.  Doge  and non-human 
15 primates  are usually unacceptable because  of the:i.r relatively long life spans,  unless the 
nature  of the toxicity or the procedures  req:uired necessitate the use  of large species. 
Historioal information should be av·ailable  on the speoifio pathological  a.l terations in the 
species and  strains studied.  The  use  at inbred vel"sus  outbred animals  remains 
contx·oversia.l. 
Consideration of the  experimental designs whioh have been suggested favours  the use  of 
adequately sized control and teat groups.  If adequate historical comrol animal data 
are available,  one  contemporary control group for  eaah  sex and speoiea  IIU:f'fioes.  It such 
clata are not  available, larger oorrtrol populations may be necessary.  The  use  at separate 
control groups,  one housed together with the test  groups  and the other in a  separate 
control  room,  remains  controversial.  Similarly, design variations which  include the 
provision of a.d.di tional animals for interim sacrifices or the setting up  of an experiment 
with  greatly increased numbers  of test animals  exposed to the lowest  do•es  of teet substance, 
are applicable  only if d~gent reasons exist tor the use at such  special experimental  designs. 
It is suggested that three dose levels apart f'rom  controls  should be tested.  The  highest 
level  chosen  should, be the  one  whioh in subohronic tests induces  no  overt toxicity or tarlc 
manifestations,  and is predicted not to shorten the life span of the animals except  as a 
result  of neoplastic develo}:Glent.  Furthe:nnore, it should not retard the weight  gain by 
more  than lo%  as  compared. to control animals,  and should take into account metabolic and 
pharmaookinetio data. 
For food additives, which are essentially non-toxio chemicals, it may  prove  impossible to 
identify a.  dose  l~!V~l which is toxic,  or the administration at the ma.ximum  tolerated level 
Dla\Y  entail such  JTJ..t~,;;.~;r  alterations to the composition of the diet, that a  meaningful 
experiment  ia  <rupc~~i  ble.  The  administration of d.oses  of ~  oanpound at  dose levels in 
excess of  r:!/c  ~~:·  ·~t1.-t.:.  i:iet  may  cause non-specific chronic toxic ef'teots and these may  in 
turn in£1  uenc~-~  .J~u..:t~ c;u·;:- incidence non-epecitically.  In suoh  oases the highest  dose level 
should general:·.,:·  ~-'+  ~;,et  at  'Y/o  of the diet. 
If the  design of the experiment  incorporates in utero exposure,  not  routinely but  only 
if specific considerations  demand it, then the highest level tested should not  be detrimental 
to conception rates, foetal  or neonatal  survival  or post-natal develo}Dent.  Such  complex 
designs  involving exposure before birth are useful for investigation af the possibility of 
transplacental  carcinogenesis.  The  use  ot newborn animals because at their possible greater 
susceptibility to oarc:i.nogens  is complicated by the oonoanita.ntly increased difficulty 
in illterpreting the  resul·ts  of tests.  Newborn  animals are difficult to expose to 
accurately measured doses  except  by  the pa.re:ateral  route and some  species are prone to 
respond under these circumstances with an increased tumour incidence  even if agents are 
used which  do  not  induce tumours in adult animals. 
Exposure to a  test substance is currently required for the major portion of the life span 
af the species used.  Provided adequate husbandry is practised,  a  24 months  post-natal 
exposure  period is generally considered adequate for both rats and mice.  Ideally, all or 
most  animals will  survive for this period, at whio..lt  time term.i.nal  sacrifice should be 
perfonned.  Exceptionally,  provided that dosing is continued for at least 18 months in 
mice and 2  years in rats, there may be  adva.nta.ges in stopping exposure therea:tter provided 
observation of the animals is continued un:til  sacrifice. 
rrhE'  resul  te af  a  ca.rcinogenici  ty test in mioe would  not  nonnally be  regarded as negative 
u11less there was  a.  7~  to Bo%  survival at the animals in each test group for 18 months  f'rom 
the start of dosing.  A similar survival rate over 2  years  should be  expected in rats. 
The  optimum  point  of termination of the experimerrt  m.a.;r  be influenced by the increasing 
incidence  of  spontaneous diseaae,  including malignant  diseaae, with the age  of the 
animals.  The  duration will thus vary and  sacrif'ioe l1la\Y  take plaoe at the  planned endpoint 
of the  experiment,  or there may  be advantages in oon:tinuing the experiment.  Some  protocols 
suggest to effect terminal sacrifice when  2J:11,  of the second highest test group survives. 
Although  survival up to 30 months  or more might  permit  greater expression of any 
carcinogenic effect,  spontaneous tumour rates also inorea.se markedly in advanced age  and 
th:i.s  effect may  mask  a  positive effect..  There is little available data to suggest that 
evidence  of  carcinogenic effect in mice  or rats first appears  only after 24 months  of 
chronic  exposure. 
16 g)  Other toxicolof2.cal  imrestiga,tio~ 
Progress in toxicology has led to the exploration of new  avenues  which may  be valuable in 
the  overall aim  of making toxicological evaluations ot safety more  a.oourate and  canprehensive. 
Rapid advances have been made  in suoh areas as immunoto.x:ioology  and behavioural toxicology. 
New  procedures are constantly being deweloped  and the problems  of interpreting animal 
observations in theee fields in terms  of human hazard are being gradually overcome.  The 
state at the art in these areas at toxicology haa  not yet reaohed the stage where  generally 
acceptable protocols can be recommended.  This ia not to be interpreted as  a.  judgement  that 
experimentation directed towards  exploring the potential for causing adverse etfeots in 
these fields has no praotioal utility.  Caution has to be exercised, however,  in any 
&rlrapolation or  these epeoial findings in laboratoey animals to the human  situation. 
In drawing up these general guidelines the Committee ha.s  been attempting to give an overview 
or  the eta.te  of the art in the taxioologioal inveriigation of food additives as it exists 
at present.  It is a.ooepted fully tha.t this situation is subject to ohange in the light of 
new  developments  and that ·bhese  guidelines m&\Y  be revised in the future to take account  at 
advances in toxicology.  MoreOV'er  there must  be treedan for the tax:ioologiet to modify 
procedures  or use alternatives.  If this is being dona,  however, valid reasons for suoh 
changes must  be  presented for appraisal. 
INTERPRETATION  ANJ?  EV' .!.LUATIOlf  OF  TEST  RESULTS 
Because the safety of a  food additive oan never be proven absolutely, the word "safe" has 
to be interpreted in some  oiroumstanoes as meaning a  socially aooeptable potential risk 
under the existing or predicted oondi  tiona  of  consumption or exposure.  When  t o:x:io  or other 
undesirable effects are tound in test procedures, it is almost  a.lw~ at exaggerated dose 
levels.  It then becomes  necessary to estiaate the probability ot a  similar response at 
dose levels enooun·tered under normal  conditions at  consumption.  For this purpose an estimate 
of the total dietary intake of the food additive trCID  all souroes is essential.  Such  data 
may  be  obtained by extensive total diet studies ot various  sample  populations and by diet 
a.nalyses to determi·ne  as accurately as poaeible the pattern ot teohnologioal use  of the food 
additive.  Recourse m~  be had to na1iional diet surveys for estimates at consumption levels 
of individual  components  at the diet both for average and high  consumers. 
When  toxicological  and other relevant data are submitted r·or evaluation the first aspect to 
be  considered is the manner in whioh they have been obtained, their completeness  a.nd  relevance 
to the assessment,  the possibility at checking their validity and whether the laboratory 
oiroumsta.noee  were  acceptable in terms  at modern laboratory practice.  In evaluating the 
results of adequately performed toxicological studies attention should be directed initially 
to the nature  of the  observed biological aotivity.  Purthermore, it is important to decide 
whether acy observed effects are reversible or irreversible, whether they are cumulative, 
and whether the.y are at a  purely functional  or purely morphological nature or both. 
Another  consideration concerns the predictive -value  of the test performed and  whether 
any dose-effect  and dose-response relationships oan be established. 
The  concept  of acceptable daily intake 
The  aim  of the toxioclogioa.l investigation of  axcy- food additive has been to establish the 
safety-in-use of the add.i tive.  In most  oases  ~his will result in the establishment  of 
an acceptable daily intake  (ADI)  for man.  'ftle latter was  defined originally by the 
Joint PJ.O/WHO  Expert  Canmittee  on Food Additives as representing the a.vera.ge  amount  of a 
substat'l.oe,  expressed 'in mgjkg  body weight,  whioh  can be ingested daily in food thrQU8hout 
the human life without  any obvious hann to health  on the basis at all known fa.ots  at the 
time  at evaluation. 
Where  an ADI  is expressed as "no upper limit specified", this means that,  on the basis  at 
the av&ilable toxicological, biological, ah•ioal and clinical da.ta,  the total daily intake 
of the substance,  arising fran its uee  ar uses at the levels necessa.r,y to achieve the 
desired teohnologi.oal effect  and :f'ram  the aooeptable background in food,  will not in all\V  at 
these oircumatanoes  represerrb  a  hazard to health.  For this reason the establishment  of a 
numerical  limit for the ADI  is not  considered necessary for these subetanoes. 
17 In certain oiroumstances it is not  possible to establish a  numerical value for the A.DI  trom 
the available taxioologioal data by the usual classical procedures.  Nevertheless appraisal 
of the toxicological information allows the oonoluaion to be drawn that the uae  ot the 
substance for a  limited period would preaem  no hazard to the health ot the consumer aDd 
that there are no  grounds tor suspecting that the subrianoe is toxio.  'l'o  cover this 
situation the oonoept  ot a  "t•porary ADI"  haa been developed,  subject to the following 
conditions  a 
i)  -tile  available biochemical and toxioologioal data,  even it  inoc:.plete,  are nevertheless 
wf'fioiently extensive to exclude the poaaibility of  8J.V'  riak to health ot the  ooJUIUIIler 
during the period. at validity at the temporary ADI J 
ii)  a  higher safety tactor must  be used in establishing the temporary ADI; 
iii) the period of validity at the t•porary .ADI  is limited to that required tor oaapletion 
o£  a.t"zy"  taxioologioal studies in progress, this ie generally 3-5 years; 
iv)  the nature  of the research to be UDderlalcen and ot the additioDal in:f'omation required 
ia clearly stated and the reasons tor requewting their provision tully explained. 
In the  end this course  o£ action will permit an estima:te to be given at the ADI  ot the 
subatanoe based  on oanplete tOid.oologioal data. 
The  concept  at "no effect level"  (DL) 
The  objective ot quantitative tax:ioologioal studies is the determination at the level of a 
substance that  can be included in the diet of experimental animals without tcn:ic eftectse 
However,  in designing toxicological studies it ie neoessar,y to use deliberately doses 
producing a.n  effect in order to determiu target  or  gaDS  and  g:i. ve some  indication of the 
nature  of the toxic effect.  With  certain substances even the highest level that  can be 
incorporated i.n a  diet fails to produce  8l1;Y'  observable ef'feote.  HCMever,  some  food 
addi  tivee do  exert toxic effects when f'ed at high levels.  For these the maximum  no-effect 
level should be determined in the most  appropriate animal  species and be based on the most 
pertinent  criteria or  toxicity. 
The  idea of a  NEL  derives frc:xn  the  olasaioal phama.cologioal  concept  ot a  dose-ef'teot 
relationship controlling the effects at chanioal agents  on biologioal  myate~~s.  As  a  corollary 
there must  exist  a.  threshold dose below which  no etteot oooure.  In the pari toxicology 
has  relied on standard experimental protocols.  Chemicals were  admin:Lriered to groupe  ot 
animals,  a.nd  the develoJIIlent  aDd health at the animals were monitored by known  clinical 
laboratory and  pathological techniques.  In modern  toxicology special experimen:ts are 
designed for assessing a  partioular etteot q~itatively under highly standardized 
oondi  tions by establishing a  dose-eft  eat curve.  i!le obeerved biological oh.anges  are 
related to blood and tissue levels at the compound  or its active metabolites.  Suoh 
experi.mental procedures  eno011pus the etfeots ot 8hemioals  on a  large rmaber at enz,matic 
and metabolic prooeases and molecular biological evema.  Theae effects are o1'ten not 
aooaapanied by overt pathological or hiatopathologioal. maniteriationa, neither need they 
be aaaociated with measurable alterations in organ f'lm.otiona.  Emphasis has shit-ted 
theretore tram the detemination ot a  IlL to a  detailed analysis r4 the tull spectrum ar 
biological everrta ilt'la.riably induced when a  foreign subatanoe e:rrters  a  living organi8JI. 
A  oonaequenoe  at this new  approach is the difficulty in determining a  RBL  in the classical 
aenee  ot the word.  The  observational limits are determined largely by the sophistication 
ot the investigator1a  tools.  There lllaJ' be orders  at magnitude between the BEL  determined 
by light microsoopy,  electron aicrosoop,y and highly sensitive bioahamioal  proaedures. 
Clearly any  NEL  determined by these nonclaaaioal taxioologioal procedures  cannot be used in 
·the  same  way for eatabliahing !Dis as the BL determi.Ded by the muoh  cruder and leas 
sensitive standard toxicological methods. 
It has been pointed out in m~  disousaions that a  variety o£  etf'eots may  occur in to.xioolog-
ioal experiments ·that are de•ed ncn  to 'be  ot 'taxicological. sigrd.tioanoe.  If suoh etf'ects are 
purely attributable to ncmul-.pb.7&1Gles:Lcal  ad~uatmeJD to metabolic  cwe:rload,  they mq be dia-
rega.Med when  eatablishiuc a.  11&.  K&l'V'  ot  ·the aub'ble .tteoiJa detectable by sophiat'ioa'ted 
methodology m"' tall imo this category .of phJ'8iolori..U.  ad&P'ation,  'tnn  often preoi•e proo:r 
1Dicy'  be d.itf'iou.1t.  In J!l8lliY  ineianoea even theae more  escnerio efteote require oorusideration 
and ~v  stimulate research whiob.  will aaeiri in eriabliahirag ute lwele ~  uae ot a  nbrianoe. 
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The  assigranent  of  a  NEL  for es·tablishment  ot·  em  ADI  should be basAd  in p;i-~~-i-;ie--~ -th;--------.. 
outcome  ot  corwe:r:rtional.  methodology in aubohronio  and.  obrcn1o aniJaa.l  studies conducted 
according to generally a.ooepted  "ola.ssioal."  to.:x:ioologioal  protocols.  However,  evaluation 
at the :f\tll  apeotrum  at biologioa.l  u-reots of subetanoes  should be enootU:'"aged  WJing the 
appropriate experimental techniques.  '!'he  results obtained should be ranked by  comparison 
with  other compounds,  whose taxic potential in rnan  is better understood, thus permitting 
a.  sound  welu.ation of the tcxxioologioal  aigni:tica.noe  of'  the data.  o·btained and the establish-
ment  at an A.DI  supported ·by  more  relwauat biological data ·than. wau.ld be available f'raa: 
"claasioe.l" methodology. 
At  the oao.pletion of  tOl:i.oologioa~ studies of food additives in experimental a.nimals  a  HEL 
may  be determined f'or laboratory speoiee,  expressed in mg~  in the diet.  Suitable conversion 
factors  allow the  establishment  of the corresponding la.boratoey animal  intake in m.g/kg  body 
weigh·t  per day,  taking :i.n1Jo  a.ooount the average weight  ot the a.ni.mala  and the mean daily food 
ooneumpt:J.on. 
In extrapolating this laboratory animal intake to man  in the form  of  a.r.i.  acceptable daily 
intake  (ADI)  for man  some  safety fa.otor ia necessary.  This sa:f"ety factor includes 
oontl"ibutions specifically designed to cover differences in species sensitivity; the 
heterogene:!.ty  of the exposed humal1  population with regard -to  health,  pregnancy, 
phyaiolog.i.l1al  status and nutrition;  synergistic or antagonistic a.otion among f'ood  ad.d.i tivee 
and  with  other ocJmponents  of foodJ  as well as age differences between expoeed individuals 
a.r.ui  the known  ~ra.x-iability with age in eru.sc•})tibility to the potential adverse effects at 
an  ingested :f'oreign substance. 
Classically an  arbitral~ safety factor o.t  100 has been widely aooepted but it would be 
unreasonable to apply this fa.otor rigidly in all oiroumsta.noes.  There are  oiroumstanoes 
Justifying the use  at a  lower ma:f'ety  factor, for example.,  if the food additive is an 
esserttial  nu:tritnxt,  a  normal  constituent ot the body or metabolises into subsiie.ncee with 
similar oharacteristics.  Similar oonsid.erations would apply if the ori  teria for establishing 
a.  NEL  fail to disregard etfeote  of dc,.ubtful toxioologioal sigl'lifioanoe1  or it valid hUIWl 
data are available. 
On  the oth$r htUld  there  JDa\Y  'be  approprl.ate  reaaona tor inore&linp: th• elle1y taotor. 
Examples  of"  au.oh  oiroumate.noes 9  although these are unlikely to apply to aooepi;a.ble food 
a.ddi tivea,  at•e  the particularly aeriou.s  aignifioanoe  of  observed tax:io effects following 
deli  berate cnrerdosage  1  e.go  deleterious ef'teots  on major  organs  sua'h  as kidney, liver or 
the oentral nervous  system,  or the matenoe of a  teratogenic or mutagenic potential. 
Other situe.tion.a are ·the  need to maintain the oolttinued use of ·the food additive even if 
the available ·toxioologioal information is not fully adequate in all respects.  Similar 
considerations may  apply, if exposure to the food.  additive shows  wide ve.riations in intake 
by critical population groups  or if the t'ood additive is proposed for use in food. it•• 
consumed  preferentially by sensitive popula:tion groups,  such as  ohildre11.  Evidence for 
ayn~rgistic effects ma..y  also  justify an increase of the safety factor.  Thftre  are a  few 
u~oi&l 11.1ituations  in whioh  orltioal groups lll&y  diaplay uoeeaive au•oeptibility to eJ)41oif'1o 
to:x:io  e:tt•e~<.naa  of  a  foreign substance to which they a.re  exposed.  In thaee oases it mq be 
prudent  among  other measures,  to use safety factors higher than those normally eaployed in 
establishing ADie. 
The  ADI  concept,  in its  ola.s~Sioa.l  a.nd  modified  fo:rm~~J,  ha.a  proved to be  of  i.mmea.eura.ble 
lJenefit  a~.noe its: initial developnent for the evaluation  CJf  the health hazards for man  of 
almost  a.ll  env:i.ronmental  aubsta.noes.  It represented the beat pra.otioal  approach for 
establishing the acceptability of intentional and unintentional f'ood  a.dd.iti.vea,  pesticide 
residues 9  food  contaminants.,  etc., and offered a  mea.DS  at achieving some  uniformity of 
approach in the regulatory control  at these subuta.noes.  It has served and  continues to 
serv·e its purpose well in the great majority ot oa.ses,  ·where  ;  .. t  is being applied.  Neverthe-
less oertain diff'icultias·!in applying the .A.DI  oonoept to e.ll  situations have led to 
suggestions for alternative approaches. 
lQ In establishing numerical values for ADia  it must  be r•embered that these are intended as 
a  guide  and are themselves based on experimemal data Bhowing  a  large variability.  They 
should not be  regarded as mathematioal  concepts indicating a  sharp demarcation between 
safety and health ha2'lard..  ADis  are oaloulated from  animal  experimeuts by the use  at largel.r 
arbitrary aa.fety factors  and thus  contain a  sa.fety margin suah that in expert  judgement 
there need be no  undue  concern when the ADia  are  occasionally or slightly exceeded.  These 
circumstances therefore do not  constitute a  hazard to the health ot the  consumer.  Minor 
fluctuations in daily intake of'  a  food additive above  and below the  ADI  are usuaJ.ly 
self-oompensa..ting if' averaged  over long periods.  However, it the ADI  appears fran 
estimations ot ir.rtake to be  exceeded tor long periods,  expert rea.ssea•ent  at the 
situation may be required.  Even then the situation will differ tor tood additives with 
practically no toxic potential and tor those with  some  evidenoe of a  to:rlo response in 
laboratory investigations.  In ·the latter oa.ee  reevaluation would have to be more  searohing 
tn depth  and extent. 
Ertra;eola.tion of results in animals to m&rj 
Undoubtedly the most  satisfactory evidence  on which to base an assessment  of human hazard 
would be  adequate human  studies.  The  ditfioulties and limitations arising in the pursuit 
ot this approach  only rarely permit  evaluation by this procedure.  Reliance has therefore 
to be placed on animal  experiments together with the assumption, that man  reacts essentially 
like the most  sensitive species tested unless there ie proof to the corrtra.ey.  '!'he  more oca-
parable the selected test species im to ma.n,  'tlle more oertaia extftpola.tion woul'd be. Unt~ 
tunately, this ideal can rarely be  .. aehiev•d a.JI4·:oognia&nce  1ll'\'llt  be t·akea ot the variability in 
response  and sensitivity at d.i:r.tere·nt  animal  species and  rirains selected for laboratory 
riud.iea.  Sensitive and  relevarrt  criteria at toxicity are recJ[uired tor extrapolation at 
the results  at animal  experimexrtation to IIWl• 
A number  at important factors  need to be  considered in this procedure.  These are: 
1. The  uncertainties inherent in quantita-.ive animal data.,  tor instance the failure to 
o'bserve  an adverse efteot because of the lim.i  ted number  of animals whiah  oan be used 
in toxicological studies.  other unoe:riainties arise from the failure to deteot human 
toxic responses tor which  no  adequa:te  animal  experimental models  ex*st• 
2. The  choioe  at functional  and morphological  ori  teria for determining the  NEL  which  are 
governed by the scope  of the experimerrt. 
3. The  difference in body size between experimental  a.nimals  and ma.n.  Man  has also a  lower 
metabolic rate per unit  bo~  weight  compared to small laboratory animals  and may  differ 
in his oapaoity for biotransformation and pharmaoOkinetio handling ot foreign substances. 
4•  The  species  specificity in reacting to the presence  of a  foreign substance in the b~ 
resulting in qualitative and quantitative differences in toxic manifestations obsened 
in man  and laboratory animals. 
5. The variability of the reactions within the human population arising from  differences in 
genetic disposition,  age,  nutritional status, health status,  environmental  circumstances, 
climate, etc.  These variations a.re largely controlled in the homogenous  animal 
population used for t ax:icological testing. 
6.  The  possible interaction of tood.  additives with  other substances  simultaneously ingested 
by man. 
Special considerations  a.pply to substances  shown to h&V'e  oa.roinogenio and/ or mutagenic 
etfeote.  These may  aot either directly or after metabolic activation with appropriate 
macromolecular targets in the affected body cells and constitute primary genotoxio 
oanpounds for which thresholds probably do not  exist.  There are also other compounds 
with similar end effects whioh  do  not act by these direct mechanisms  and these constitute 
epigenetic carcinogens  or mutagens.  The latter substances have different properties :from 
genotoxio  oaroinogens  and for these a  threshold  may exist.  In principle substances  shown 
by adequate bioasaays to be potentially genotoxic in animal a  should not be added to the human 
tood supply.  !his consideration l1l8\Y'  not  apply as rigidly to subs·tanoea acting by epigenetic 
mechanisms. 
20 For  subs-tances with  purely heritable mutagenic potenti.al, whioh  do  not  produce  any positive 
results in adequately performed  carcinogenicity bioase~s, there is at present  no  possibility 
of making quantitative risk assessments in terms  of the induction of increased mutation 
frequencies in man.  Here  only broad categorization of mutagenic activity can be achieved, 
based  on appropriate  combinations  of the outcome  of in vitro and in vivo genetic toxicity 
tests for different genetic endpoints.  Interpretation of these results on their own  in 
terms  of hwnan  mutagenic hazard is not  possible at present  and  aey evaluation has to be made 
on  the basis of all available toxicological data.  Each  compound  has therefore to be 
considered  on its merits. 
Special  considerations 
For certain classes of food additives such  as flavouring substances,  processing aids, 
e.g. filtering aids,  and f'ood  packaging components,  the extent  of the toxicological 
examinations described above may  need to be modified appropriately.  As  an  example,  in the 
case  of flavouring agents,  different  considerations may  apply when  evaluating their 
safety-in-use.  Many  of these substances occur in natural food products  or are used in 
minute  concentrations in a  few foods  only.  Orl  the other hand,  many  have  not  yet been 
full  characterised.  As  these substances are very numerous,  priorities need to be  established 
regarding the substances to be evaluated,  giving at the  same  time due  consideration to the 
extent  of the toxicologioal  examination required.  It mus-t  be remembered,  however,  that 
no  toxicological evaluation can be made  in the complete  abaen~e of  information (see also 
page 8).  An  example  of a  posai  ble approach is the one  used by the Council  at Europe. 
~1e 21st  Report  of  JECFA  gives an example  tor the selection of criteria for priorities. 
For components  of food  paCkaging materials guidelines have already been published1• 
In the case of  processing aids the requiremems for toxicological examination m~  be 
reatriated, if the  substances are clearly defined and specified, if they have  a  satisfactory 
degree  of purity, i! they are essentially removed  during processing without  leaving reeidues 
or by-products or substances resulting from  reaction with food components.  In other 
oiroumstances their potential health hazards have to be  evaluated,  depending  on the nature 
of the substance  and  of ~  reaiduea appearing in the processed food. 
A.N!fEX  PRO  M!MORIA 
It is proposed,  at  a  later date,  to include as an Annex  more  detailed protocols for 
eonducting toxicological inveatigatiotlll.  These are at present being establiahed in 
international fora and their applicability f'or the toxicological  examination of food 
additives will be  considered by the Scientific Ca.mittee for Pood.  The  Committee  intends 
to propose minimum  requirements rather than detailed test procedures. 
Similarly the Committee will be considering the proposals for good  laboratory practice 
at present being elaborated within the EEC  and make  appropriate suggestions for application 
in the field of food additives. 
!Reports at the Scientific COIIIlittee tor :rood, 'l'hird Series, 1977. 
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